Evidence map›Paper›PMID 30235884›Full record

ReviewGenes2018

Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens.

Ewa Ksiezopolska, Toni Gabaldón

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 241 citations in OpenAlex.

  1. Article
  2. Article
  3. Isobavachalcone effectively inhibits the growth ofAntimicrobial agents and chemotherapy · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  9. Article
  10. Article
  11. The Prevalence and Drug Susceptibility ofAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. In Vitro Evaluation ofInternational journal of molecular sciences · 2025
    Article
  14. Synergistic activity between conventional antifungals and chalcone-derived compound against dermatophyte fungi and Candida spp.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  15. Article
  16. Review
  17. Threats from theMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  18. Review
  19. Evaluation of Fifteen 5,6-Dihydrotetrazolo[1,5-Journal of fungi (Basel, Switzerland) · 2024
    Article
  20. Review

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ewa KsiezopolskaBioinformatics and Genomics Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain. ewa.ksiezopolska@crg.eu.
Toni GabaldónBioinformatics and Genomics Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain. toni.gabaldon@crg.eu.
Centre for Genomic Regulation · ESPompeu Fabra University · ES

Funding

H2020 Marie Skłodowska-Curie Actions H2020-MSCA-ITN-2014-642095Ministerio de Economía y Competitividad BFU2015-67107
6 · The paper itself

Abstract

Fungal infections, such as candidiasis caused by

Indexed as

antifungal drugsCandidadrug resistanceevolution

Identifiers

PMID30235884
PMCPMC6162425
OpenAlexW2891298374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.